|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.5208 USD | -2.93% |
|
-5.22% | -52.65% |
| 08-28 | L.I.A. Pure Capital Issues Response to Evogene | CI |
| 08-25 | Institutional Shareholder Services and Glass Lewis Makes Recommendations to Shareholders | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOGENE LTD. | Other Biotechnology & Medical Research | -2.93% | -5.22% | -52.65% | -58.34% | -98.28% | 7.24M |
-
|
-
|
-
|
- Stock Market
- Stocks
- EVGN Stock
- EVGN Stock
- Charts Evogene Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
